CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 13 No. 1
The Garay/Engstrom Article Reviewed 

Chemoprevention of Colorectal Cancer: Dietary and Pharmacologic Approaches

By María Elena Martínez, PhD, Arizona Prevention Center and Arizona Cancer Center, University of Arizona Health Sciences Center, Tucson | January 1, 1999

Remarkable progress has been made in recent years in our understanding of colorectal cancer etiology. The various hypotheses of causality continue to be tested in human observational and intervention studies, as well as experimental models. Drs. Garay and Engstrom provide a comprehensive review of the dietary and chemopreventive factors for colorectal cancer. While their conclusions are noteworthy, those related to dietary factors are debatable.

NSAIDs

Results of epidemiologic studies indicate that use of aspirin(Drug information on aspirin) and other nonsteroidal anti-inflammatory drugs (NSAIDs) reduces colorectal cancer risk by approximately 50%. Perhaps the strongest evidence to date for the preventive activity of aspirin comes from the Nurses’ Health Study, which showed a 44%, statistically significant reduction in colorectal cancer in women after 20 years of consistent use. Given this long induction period, the negative results of such trials as the Physician’s Health Study, noted by Garay and Engstrom, may be due to a shorter duration of follow-up. However, as also noted by the authors, given the toxicities of NSAIDs, these agents do not seem to be a feasible strategy for primary prevention of colorectal cancer in average-risk persons.

As mentioned by Garay and Engstrom, ongoing trials, such as that being conducted by the Cancer and Leukemia Group B (CALGB), may provide further insights. The goal of the CALGB trial is to study aspirin’s effects on the development of new adenomas among individuals with a history of colorectal cancer. However, the results may not be generalizable to average- or lower-risk individuals.

Dietary Fat and Fiber

Although results of epidemiologic studies show strong correlations between per capita intakes of total fat and rates of colon cancer, it is not possible to account for potential confounding factors in these studies. Earlier prospective studies of colon cancer have shown inconsistent findings for the association of fat intake and colon cancer. One of these studies (cited by Garay and Engstrom) showed a decreased risk of colorectal cancer among Hawaiian-Japanese men with higher intakes of total fat. However, careful attention must be placed to the source of the dietary data in this study, which used a single 24-hour recall method.

The vast majority of earlier case-control studies also support a positive association between total fat consumption and colorectal cancer risk. However, many of these studies failed to disentangle the effects of total fat from those of total energy intake, which is strongly correlated to total fat. Of those studies that statistically adjusted for total energy intake, most did not find a positive association between total fat and colon or colorectal cancer.[1] Of particular importance is the combined analysis[2] of 13 case-control studies, which found no evidence of an increased risk of colorectal cancer with higher dietary fat after adjustment was made for total energy.

In addition, studies that have investigated various sources of fat suggest a stronger, more consistent association between consumption of red meat and risk of colorectal cancer. For example, data from two large cohort studies, the Nurses’ Health Study[3] and the Health Professionals Follow-up Study,[4] showed a direct association between consumption of red meat and risk of colon cancer, but no association was observed with other sources of fat.

Overall, the epidemiologic evidence for the protective role of fiber against risk of colorectal cancer is inconsistent. This may be due to the heterogeneous nature of fiber and the differences in its measurement. Although the results of two meta-analyses, cited by the authors, show a lower risk of colon cancer with increased fiber intake, these are based solely on data from case-control studies. Conversely, this association is not generally supported by prospective studies. However, a vast majority of published studies have shown an inverse association between intake of vegetables and colon cancer.[5] It is possible that the more consistent findings for intake of vegetables as compared with fiber are the result of the ability to measure vegetable sources of fiber better than nonvegetable sources.

Garay and Engstrom mention that results of the Polyp Prevention Trial should provide more conclusive information about these relationships. However, it must be emphasized that the intervention in this trial consists of an alteration in dietary patterns; therefore, any observed effect on polyp recurrence cannot be attributed to the independent effects of fiber or fat.

Vitamins and Minerals

Based on their thorough review of the literature on antioxidant vitamins, Garay and Engstrom arrive at the sound conclusion that there is insufficient evidence for their preventive effect against colorectal cancer. Regarding the role of folate, a protective effect against colon cancer is supported by few published studies. However, as pointed out by

Giovannucci et al,[6] this association must be considered together with the effects of methionine and alcohol(Drug information on alcohol) consumption, since the increased risk of colon cancer is marked among individuals with lower intakes of folate and methionine in the presence of high alcohol consumption. Since the proposed mechanism relates to dietary factors that influence methyl group availability, the assessment of folate, methionine, and alcohol in colon carcinogenesis underscores the importance of considering complex dietary interactions. Results from ongoing chemoprevention trials should elucidate this area of study.

Despite the considerable number of studies in a variety of settings, results of published epidemiologic studies suggest that higher calcium intake is not associated with a substantially lower risk of colorectal cancer.[7] The possibility that calcium intake has a weak or modest effect on the occurrence of colorectal cancer cannot be excluded, however. As noted by the authors, further insights may come from ongoing randomized trials, such as the recently completed Dartmouth trial of calcium supplementation and recurrence of colon adenoma.

Summary

Based on the data presented to date, while a positive association exists between red meat consumption and colorectal cancer, there appears to be no clear evidence for an association between dietary fat and this cancer. With respect to dietary fiber, although the particular components of fiber that contribute to a decreased risk for colorectal cancer have not been clearly identified, the current evidence suggests that a diet high in fruits and vegetables is protective. Finally, in the area of primary prevention of this malignancy, greater focus should be placed on increasing physical activity, given the overwhelming evidence for its risk-reducing potential.[8]

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Carlos A. Garay, MD, and Paul F. Engstrom, MD


1. Giovannucci E, Willett WC: Dietary lipids and colon cancer. Principles and Practice of Oncology 9:1-12, 1994.

2. Howe GR: Advances in the biology and therapy of colorectal cancer. Presented at The Thirty-Seventh Annual Clinical Conference and Twenty-Sixth Annual Special Pathology Program, Houston, Texas, November 4-7, 1993.

3. Willett WC, Stampfer MJ, Colditz GA, et al: Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323:1664-1667, 1990.

4. Giovannucci E, Rimm EB, Stampfer MJ, et al: Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 54:2390-2397, 1994.

5. Potter JD: Nutrition and colorectal cancer. Cancer Causes Control 7:127-146, 1996.

6. Giovannucci E, Rimm EB, Ascherio A, et al: Alcohol, low-methionine low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87:265-273, 1995.

7. Martinez ME, Willet WC: Calcium, vitamin D, and colorectal cancer: A review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7:163-168, 1998.

8. Colditz GA, Cannuscio CC, Frazier AL: Physical activity and reduced risk of colon cancer: Implications for prevention. Cancer Causes Control 8:649-667, 1997.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy